Titan Medical's director of strategic development earns global IP strategy leader recognition: 3 notes

Written by Mackenzie Garrity | June 21, 2018 | Print  |

Intellectual Asset Management named Titan Medical's Director of Strategic Development Jasminder Brar a global intellectual property strategy leader.

Here are three notes:

1. As a leader, Mr. Brar will be featured in the 2018 editor of IAM Strategy 300 - The World's Leading IP Strategists.

2. Those named leaders are regarded as experts in developing and rolling-out strategies to maximize patents, copyright, trademarks and other IP rights.

3. This is the fourth year Mr. Brar has been included as a leader.

"Intellectual property continues to be absolutely vital to our success and we are proud that Jasminder's leadership of our efforts and accomplishments has been recognized," said David McNally, president and CEO of Titan Medical. "I want to congratulate Jasminder on his inclusion in the IAM Strategy 300 for the fourth consecutive year and acknowledge his leadership and know-how in advancing our strategic intellectual property efforts."

More articles on devices and implants:
The state of the medical device industry: 10 key thoughts
Zavation names former RTI Surgical CEO Brian Hutchison to board of directors: 4 highlights
J&J opens 3rd institute in China as Trump threatens new tariffs: 5 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months